This may in part be explained by the inherent intra-tumor heterogenity within GBM tumors, with previous studies demonstrating spectral expression patterns for both SOX2 and pSTAT3 including GBM (1, 33, 34). The gene discussed is SOX2; the disease is glioblastoma.